Liberal Versus Restrictive Transfusion Strategy in Critically Ill Oncologic Patients-Reference-Cited by-同舟云学术

Liberal Versus Restrictive Transfusion Strategy in Critically Ill Oncologic Patients

Published:2017-05 Issue:5 Volume:45 Page:766-773
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Bergamin Fabricio S.,Almeida Juliano P.,Landoni Giovanni,Galas Filomena R. B. G.,Fukushima Julia T.,Fominskiy Evgeny,Park Clarice H. L.,Osawa Eduardo A.,Diz Maria P. E.,Oliveira Gisele Q.,Franco Rafael A.,Nakamura Rosana E.,Almeida Elisangela M.,Abdala Edson,Freire Maristela P.,Filho Roberto K.,Auler Jose Otavio C.,Hajjar Ludhmila A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference30 articles.

1. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

2. Outcomes in Critically Ill Cancer Patients With Septic Shock of Pulmonary Origin

3. Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit*

4. Cancer patients with septic shock: mortality predictors and neutropenia

5. Critically ill patients with cancer and sepsis: Clinical course and prognostic factors

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Septic shock in the immunocompromised cancer patient: a narrative review;Critical Care;2024-08-30

2. The impact of perioperative transfusions on the oncologic outcomes of patients with ovarian cancer: A population‐based study;Journal of Surgical Oncology;2024-08-27

3. Oncology Intensive Care Units: Distinguishing Features and Clinical Considerations;Journal of Intensive Care Medicine;2024-08-23

4. Perioperative Blood Transfusions and Cancer Progression: A Narrative Review;Current Oncology Reports;2024-06-07

5. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support;Cochrane Database of Systematic Reviews;2024-05-23